An official website of the United States government. Bethesda, MD 20894, Web Policies HHS Vulnerability Disclosure, Help Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature JAAD Int. Cazzato G, Ambrogio F, Foti C, Capuzzolo M, Trilli I, Casatta N, Lupo C, Carrieri M, Daini D, Colagrande A, Maiorano E, Ingravallo G. Diagnostics (Basel). Drago F, Ciccarese G, Rebora A, et al. 2021;28(16):1992619943. PRISMA, preferred reporting items for systematic reviews and metaanalysis. COVID-19 vaccine hesitancy is a critical problem that hinders Numerous scattered erythematous plaques with fine scale oriented along skin cleavage lines, most appreciable on the upper portion of the chest. Following the national COVID-19 vaccination guidelines, she received a shot of ChAdOx1 nCoV-19 (AZD1222) vaccine before the therapy. SPSS statistical software version 25 was used for appropriate inferential statistics. Abdullah L, Hasbani D, Kurban M, Abbas O. Pityriasis rosea after mRNA COVID-19 vaccination. Epub 2021 Apr 26. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. Clipboard, Search History, and several other advanced features are temporarily unavailable. Careers. Received: 03 August 2021; Accepted: 17 August 2021; Published: 07 September 2021. Please enable it to take advantage of the complete set of features! Then you may get smaller spots that sweep out from the middle of the body in a shape that looks like drooping pine-tree branches. The authors of one 2014 case report of a 71-year-old man who suffered from pityriasis rosea one month after receiving an influenza vaccine concluded that "altered immunity" could result in. No HHV-6 and HHV-7 reactivation is detected. Background: After introducing Covid-19 vaccines, a few side effects were reported, pityriasis rosea being one of them.Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022.Data were independently extracted and accessed for bias. J Am Acad Dermatol. (2017) 5:20311. All patients are currently in good general health. Scleroderma or CREST syndrome is a chronic, auto immune disease which manifests as. A 3-cm oval plaque with peripheral scale, larger than the other lesions, was present on the inferior portion of the right breast. The most commonly inoculated vaccines include those against smallpox, followed by tuberculosis, poliomyelitis, influenza, and human papillomavirus virus (12, 13). Involvement of the oral mucosa has also been reported in as many as 50% of all cases (11). This site needs JavaScript to work properly. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Epub 2022 Oct 17. McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Literature data about PR/PRLE after anti-SARS-CoV-2 vaccination may be summarized as follows: i) the infection occurs both in males and females (in several articles the gender was not reported); ii) the age ranges from 19 to 82 years (the count of the mean age is impossible because in several articles patients age was not specified). Akdas E, Ilter N, Ogut B, Erdem O. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. Epub 2022 Feb 9. Before 10.1136/POSTGRADMEDJ-2020-138234 Clinical manifestations and histopathologic findings of reported patients with pityriasis-rosea like eruptions following COVID-19 vaccination. doi: 10.1111/dth.13650, 7. Accessibility 8600 Rockville Pike Numerous scattered erythematous, Pityriasis rosea. (2016) 55:e33843. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. N Engl J Med 2020; 383: 2603-2615. Ciccarese G, Parodi A, Drago F. SARS-CoV-2 as possible inducer of viral reactivations. Clin Dermatol. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). Pityriasis rosea after mRNA COVID-19 vaccination. As with eczema, the conditions can be differentiated under the microscope by their acanthotic or non-acanthotic appearance. The vaccination campaign has been the most important strategy to combat the COVID-19 pandemic. SARS-CoV-2 vaccine; cutaneous side-effects; infection; papulosquamous; skin diseases; vaccine hesitancy. J Med Virol 2021; 93: 1850-1851. Drago F, Ciccarese G, Javor S, et al. Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID19 MapJohns Hopkins Coronavirus Resource Center. The site is secure. It often presents with diffuse and confluent severely pruritic dusky-red erythematous lesions in the absence of herald patch (11). sharing sensitive information, make sure youre on a federal Federal government websites often end in .gov or .mil. Although the most severe manifestations concern the lower respiratory tract, COVID-19 is a multiorgan disease that also affects the skin. The present study investigated a case of pansclerotic morphea that rapidly progressed a few weeks after infection with COVID-19 in a 57-year-old woman with no history of any autoimmune skin or rheumatic diseases. Histopathologic examination revealed epidermal focal spongiosis, interface dermatitis with necrotic keratinocytes, perivascular lymphocytic infiltration, and few eosinophilic infiltrations in the superficial dermis (Figures 3B,C). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. FOIA Some patients may have a cold before the rash. Moles, psoriasis, hives, eczema, and recently associated Covid-19 coronavirus rashes are just a few of the more than 3,000 skin disorders known to dermatology. Federal government websites often end in .gov or .mil. The length of the rash is shorter in comparison with PR.19. Br J Dermatol. Dursun R, Temiz SA. Bethesda, MD 20894, Web Policies Six weeks prior to the appearance of the initial skin lesion, the patient had coronavirus disease 2019 (COVID-19) infection with mild clinical presentation (fever up to 38 C lasting for four days and mild headache) and with symptoms of post COVID-19 syndrome (excessive tiredness). The advent of vaccines has drastically reduced the incidence, morbidity, and mortality related to COVID-19 [1]. Due to the temporal relationship between vaccination and onset of rash, COVID-19 vaccination was the most likely etiology. Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Busto-Leis JM, Servera-Negre G, Mayor-Ibarguren A, et al.. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance, Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report, Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine. 2022 by the American Academy of Dermatology, Inc. All patients were treated with cetirizine (20 mg/day for 7-14 days). Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. 1 Several vaccines have been developed to fight against COVID19, to prevent the transmission among susceptible individuals and to decrease the morbidity Peripheral eosinophilia is often present. We report 10 . Umakanthan S, Sahu P, Ranade AV, et al. Researchers believe that MIS-C, which can cause dangerous levels of inflammation throughout the entire body, occurs as a response to COVID-19 infection (including asymptomatic cases), but many questions remain. A 3-cm oval plaque with peripheral scale, larger, MeSH 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. Veraldi S, Boneschi V, Cusini M, Maronese CA. doi: 10.1002/jmv.26549, 9. Among the common cutaneous manifestations of COVID-19 (e.g., morbilliform eruptions, chilblains, and varicella-like vesicles), PR and PR-like eruptions have rarely been described (6, 7). Here, we described a case of PR-like eruption that developed 14 days after Oxford/AstraZeneca vaccination in a 52-year-old Thai woman with glioblastoma. (2020) 83:e5760. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. Br J Dermatol. This site needs JavaScript to work properly. Suchonwanit P, Hector CE, Bin Saif GA, McMichael AJ. Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqu D, Gimnez-Arnau AM, Pujol RM, Martin-Ezquerra G. J Eur Acad Dermatol Venereol. Figure 2. However, some hypotheses may be advanced: PR/PRLE following anti-Sars-CoV-2 vaccination may be just a coincidence; anti-Sars-CoV-2 vaccines cause a reactivation of HHV-6 and/or HHV-7; vaccines can induce a delayed hypersensitivity response clinically similar to drug-induced PRLE. PRISMA, preferred reporting. Dermatol Ther. Common causes of drug-induced PR-like eruptions include angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs, and gold. The .gov means its official. Polack FP, Thomas SJ, Kitchin N et al. In one small study, a majority of women who got pityriasis rosea in . Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Clin Cosmet Investig Dermatol. official website and that any information you provide is encrypted National Library of Medicine Disclaimer. See this image and copyright information in PMC. Many Americans become infected with them at an early age. National Library of Medicine tions reported after vaccination include: injection site reactions, urticarial and morbilliform eruptions, per-nio/chilblains, reactions to cosmetic llers, herpes zoster, herpes simplex ares, and pityriasis rosea-like rashes [1]. Dermatol Reports. J Formos Med Assoc. The papulovesicular and pityriasis rosea-like patterns are equally frequent in all vaccines. Oral baricitinib for moderate to severe alopecia areata in adolescents . 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. However, after 14 days, she developed multiple discrete blanching erythematous oval patches and plaques on the lower abdomen, back, and bilateral upper thighs (Figures 1A,B). 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Since you said you felt ill at the time getting the vaccine you had covid at the time. 2023 The Authors. I got tested for covid after I got the vaccination because . As previously mentioned, only some cases of PR/PRLE after anti-SARS-CoV-2 vaccination have been reported (Table 2).1-18, PRLE usually appears following a drug, without prodromal symptoms. government site. All patients are currently in good general health. This site needs JavaScript to work properly. Keywords: adverse effect, coronavirus, cutaneous eruptions, immunization, pityriasis rosea, SARS-CoV-2, vaccine, case report, Citation: Leerunyakul K, Pakornphadungsit K and Suchonwanit P (2021) Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Hum Vaccin Immunother. Pityriasis rosea (PR) is an acute exanthematous disease. In conclusion, we have described the first case of PR-like eruption following ChAdOx1 nCoV-19 (Oxford/AstraZeneca) vaccination. We present two cases of COVID-19 vaccine-induced pityriasis rosea. NCI CPTC Antibody Characterization Program, Ritchie H., Mathieu E., Rodes-Guirao L., et al. Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. Moreover, central dusky-red erythematous was observed on some plaques (Figure 2A). Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. We originally reported patients with COVID-19 [2], Keywords: The rash most often appears on the chest, back, and belly. doi: 10.1111/jdv.17316, PubMed Abstract | CrossRef Full Text | Google Scholar, 2. Cases of EM was observed after mRNA-based COVID-19 vaccines, and after CoronaVac vaccination wich is is an inactivated SARS-CoV-2 virus [13, 14]. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review. Authors Elina Khattab 1 , Eirini Christaki 2 , Constantinos Pitsios 1 Affiliations 1 Medical School, University of Cyprus, Nicosia, Cyprus. In a Spanish study,PR/PRLE was observed in 11 patients (6.7%) vaccinated with BNT162b2, in 5 patients (3.4%) vaccinated with mRNA- 1273 and in 4 patients (4.2%) vaccinated with AZD1222.2 Available data suggest that BNT162b2 vaccine is more related to PR/PRLE than other vaccines. It is also called Christmas tree rash. Table 1 summarizes all reported cases of PR-like eruption following COVID-19 vaccination. doi: 10.1111/jdv.12942, 13. Pityriasis rosea is a rash that often begins as an oval spot on the face, chest, abdomen or back. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Mohta A, Mohta A, Ghiya BC, Mehta RD, Kumar V. Indian J Dermatol. The first sign of pityriasis rosea is often one large patch on the skin, which is followed smaller patches or bumps. J Am Acad Dermatol. Epub 2021 Aug 26. doi: 10.1111/dth.15129. Complete remission was observed within 14-30 days. FOIA Dermatol Ther. In addition to reactivation of HHV-6 or HHV-7, PR can be triggered by some drugs (like angiotensin-converting enzyme inhibitors alone or in combination with hydrochlorothiazide, sartans plus hydrochlorothiazide, allopurinol, nimesulide, and acetyl salicylic acid (2) and vaccines (such as smallpox, poliomyelitis, influenza, human papillomavirus, diphtheria, tuberculosis, hepatitis B, pneumococcus, and yellow fever vaccines) (3). eCollection 2022. Pityriasis rosea developing after COVID19 vaccination. -, Johansen M, Chisolm SS, Aspey LD, Brahmbhatt M. Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: a report of 2 cases. An official website of the United States government. Department of Pathophysiology and Transplantation, Universit degli Studi, Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy. doi: 10.1111/dth.15040, 3. The site is secure. In an American study, the average latency time was 13 days.7 In the previous cited Turkish-Egyptian study, the average latency time was 12.7 days.17 In 22 cases the eruption appeared 1-21 days after the second dose (average: 8.8 days); in 2 cases the eruption occurred both after the first and the second dose. However, in cases of atypical PR, it may present with erythema multiforme-like lesions and purpura (5). 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. (2021) 35:e4913. However, several adverse effects of COVID-19 vaccination have been identified. pityriasis rosea after covid vaccine Last month at Barret-jackson in Scottsdale, Arizona a 1929 Roadster was put up for sale by Dave Kindig of . Chanprapaph K, Pomsoong C, Tankunakorn J, Eden C, Suchonwanit P, Rutnin S. Comparative analyses of clinical features, histopathology, and CD123 immunohistochemistry of oral lupus erythematosus, lichen planus, and other lichenoid lesions. Cutis. . Six days later, she developed a rash on her. In a registry-based study, PR-like eruption was observed in only 12% of patients (14). Epub 2021 Jun 10. sharing sensitive information, make sure youre on a federal This is called the herald patch. Bookshelf Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination. J Invest Dermatol. 2021 Sep;35(9):e546-e548. doi: 10.1002/iid3.804. FOIA 8600 Rockville Pike Within two weeks of topical betamethasone dipropionate treatment, the lesions disappeared completely. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. It is believed to represent a delayed reaction to viral infections and is usually associated with endogenous systemic reactivation of human herpesvirus (HHV) 6 and / or 7 (1). MeSH 10.1007/S10354-021-00876-0 Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In some cases, central hyperpigmentation was identified. Morphologic misclassication is possible. The site is secure. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Careers. Bookshelf 2020;96(1142):753758. In 4 patients PR appeared after the first vaccination; in 1 patient after the second one. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Epub 2021 May 29. Unauthorized use of these marks is strictly prohibited. SARS-CoV-2 disease, COVID-19 infection, is a multi-system illness that has afflicted people all over the world. Zhongguo Dang Dai Er Ke Za Zhi. The association between pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccines was established, but given the scarcity of studies, there is a need to conduct different clinical trials to confirm this association further and study the etiology and mechanism of the disease. doi: 10.1111/bjd.20143. 8:752443. doi: 10.3389/fmed.2021.752443. reactions included pernio/chilblains, cosmetic ller reactions, zoster, herpes simplex ares, and pityriasis rosea-like reactions. Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. J Eur Acad Dermatol Venereol. Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Clin Cosmet Investig Dermatol. Histopathologic features: (B) microscopic image at a low power field showing psoriasiform epidermal hyperplasia, perivascular infiltration, and interface dermatitis (hematoxylin-eosin; scale bar represents 100 m); (C) microscopic image at a high power field showing focal spongiotic dermatitis, interface dermatitis, and perivascular infiltration of lymphocytes and eosinophils (hematoxylin-eosin; scale bar represents 40 m). Dermatology. 2020;33:E13730. Careers. Bethesda, MD 20894, Web Policies The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). No use, distribution or reproduction is permitted which does not comply with these terms. sharing sensitive information, make sure youre on a federal doi: 10.1111/jdv.17316. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (, Anti-SARS-CoV-2, AZD1222, BNT162b2, mRNA-1273, Pityriasis rosea, Pityriasis rosea-like eruption. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. Before Secukinumab for pityriasis rubra pilaris (December 2022) SKIN CANCER. An official website of the United States government. The four stages of pityriasis rosea are: Preliminary stage: You feel ill for a day or two. Disclaimer. The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and Kawasaki disease. Children often get infected when someone sneezes or kisses them. HHS Vulnerability Disclosure, Help and transmitted securely. SV, CAM, MC, VB, collected the data. Herald patch in the right hypochondrium followed by typical oval-shaped secondary plaques, Pityriasis rosea lesions on the upper extremities, MeSH Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. MeSH Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. National Library of Medicine PR 12.7 days (mean) after the vaccination (19 patients after the 1. Itching is often severe. Epub 2022 Jan 31. Suchonwanit P, Triamchaisri S, Wittayakornrerk S, Rattanakaemakorn P. Leprosy Reaction in Thai Population: A 20-Year Retrospective Study. Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 vaccine. doi: 10.1111/jdv.17498. Unlike in our patient, oropharyngeal lesions were observed in approximately 16% of patients with typical PR (10). Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022. 2021;35(8):e489e491. doi: 10.1111/dth.13878, 10. 2021;35(8):e489e491. See this image and copyright information in PMC. Accessibility The ones found in people with pityriasis rosea are human herpesviruses 6 and 7. An official website of the United States government. Dermatol Reports. (A) Dermoscopic features: dotted and linear vessels forming a network on a yellowish background with some whitish peripheral scales (original magnification x20). Dermatol Ther. However, some hypotheses may be advanced: i) PR/PRLE following anti- Sars-CoV-2 vaccination may be just a coincidence, for instance in those patients in whom PR/PRLE appeared only one day after vaccination;4,12 ii) anti-Sars-CoV-2 vaccines cause a reactivation of HHV-6 and/or HHV-7, which is similar to the reported association with herpes zoster;1,9 iii) vaccines can induce a delayed hypersensitivity response clinically similar to druginduced PRLE.10. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 patients) or mRNA- 1273 (2 patients). Drug-induced PR-like eruption accounts for 2% of all cutaneous adverse drug reactions (10). In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 patients) or mRNA- 1273 (2 patients). eCollection 2023 Mar-Apr. Pityriasis versicolor is caused by a yeast infection and can be treated with antifungal medicines , including antifungal creams and antifungal shampoos. They suggested that the short time elapsed between vaccination and PR onset resembled that of delayed localized cutaneous reactions occurring shortly after the second vaccine dose. Contributions: SV and CAM, conceived and wrote the article. Conclusion: Pityriasis rosea developing after COVID-19 vaccination. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. doi: 10.1111/dth.15601. doi: 10.1159/000517971. -. Bin Rubaian NF, Almuhaidib SR, Aljarri SA, Alamri AS. Spongiotic dermatitis was the most commonly reported cutaneous reaction to COVID-19 vaccination among patients who also had biopsy results available for review, according to a registry-based. 2021 Aug;185(2):e34. Bethesda, MD 20894, Web Policies Cutaneous adverse reactions of COVID-19 vaccines: A systematic review. -, Drago F, Ciccarese G, Parodi A. Pityriasis rosea and pityriasis rosealike eruptions: how to distinguish them? official website and that any information you provide is encrypted HHS Vulnerability Disclosure, Help -, Cyrenne BM, Al-Mohammedi F, DeKoven JG, Alhusayen R. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 vaccine. FOIA Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. HHS Vulnerability Disclosure, Help PMC Thirty-one studies were included for data extraction after screening following the eligibility criteria. Suchonwanit P, Rojhirunsakool S, Khunkhet S. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. The site is secure. CONCLUSION: The association between pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccines was established, but given the scarcity of studies, there is a need to conduct different clinical trials to confirm this association further and study the etiology and mechanism of the disease. The third type of rash, known as Covid fingers and toes (sometimes described as chilblains), is where red and purple bumps appear on the fingers or toes.. (2020) 33:e13878. The patients/participants provided their written informed consent to participate in this study. While COVID-19 vaccines offer strong and lasting protection against severe . Epub 2021 May 29. Accessibility J Eur Acad Dermatol Venereol 2020; 34: e436-e437. Pityriasis rosea. Before Before Several vaccines have been created to counteract the morbidity and mortality associated with COVID19 and stop viral transmission, including the Moderna vaccine (Mrna1273).The mRNA1273 vaccine is a lipid nanoparticle-encapsulated mRNAbased vaccine that encodes the prefusion stabilized fulllength spike . Adya KA, Inamadar AC, Albadri W. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations. Complete remission was observed within 14-30 days. In 3 patients a biopsy for histopathological examinations was carried out. Epub 2021 Jun 10. 8600 Rockville Pike See this image and copyright information in PMC. NCI CPTC Antibody Characterization Program. Would you like email updates of new search results? 8600 Rockville Pike NCI CPTC Antibody Characterization Program. We speculate that PR could be a delayed skin manifestation of COVID-19 infection, triggered either by SARS-CoV-2 immediately or indirectly by the reactivation of other viruses such as HHV-6 or HHV-7. Dermoscopy showed dotted and linear vessels forming a network on a yellowish background, with some whitish peripheral scales (Figure 3A). A 46-year-old man presented to our Department with a two-week history of skin rash associated with mild pruritus. However, adverse effects to COVID-19 vaccines, particularly cutaneous reactions, have been reported. 21% of people who have Covid develop a rash as their only symptom of infection. Alvin Friedman-Kien, MD, walked through the doorway into the exam room, looked at me and immediately said, "Oh, you have pityriasis rosea." He called in a bunch of residents so he could show them my rash and teach them about the condition, which often has a large patch called the "mother patch" (or herald patch), as well as smaller . Authors Jordan E Buckley 1 , Laura N Landis 2 , Ronald P Rapini 1 Affiliations Fortunately, PR-like eruption is responsive to topical corticosteroids without any systemic adverse effects. Of the 30 cases found, none experienced severe adverse effects and the rash resolved in an average of 5.6 weeks. doi: 10.1111/ijd.13061. Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. Allergy Asthma Proc. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. It starts with one large round or oval scaly patch. eCollection 2023 Mar 7. Please enable it to take advantage of the complete set of features! Efficacy and safety of COVID19 vaccines: a systematic review. Dermatol Ther. Vaccine-Related Eruptions of Papules and Plaques Following COVID-19 Vaccination - A Case Series. Few brownish patches also appeared, suggestive of post-inflammatory hyperpigmentation. -. Potassium hydroxide, syphilis, and laboratory tests were within normal limits. Factors affecting the severity of central centrifugal cicatricial alopecia. and the adverse cutaneous effects of COVID-19 . Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al. J Formos Med Assoc. Bethesda, MD 20894, Web Policies FOIA Results were typical for PR. official website and that any information you provide is encrypted The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. It is believed to represent a delayed reaction to viral infections and is usually associated with endogenous systemic reactivation of human herpesvirus (HHV) 6 and / or 7 (1).

How To Add Trusted Domain In Office 365 Admin, Ledger Swap Fees, Director Of Development Special Olympics Salary, Cdcr Visiting Reopening, Articles P